serval:BIB_92AEB095500C
Treatment and timing in invasive mould disease.
10.1093/jac/dkq440
000285628200006
21177402
Maertens
J.
author
Groll
A.H.
author
Cordonnier
C.
author
de la Cámara
R.
author
Roilides
E.
author
Marchetti
O.
author
article
review
2011
Journal of Antimicrobial Chemotherapy
1460-2091[electronic], 0305-7453[linking]
journal
66
Suppl 1
i37-i43
Invasive mould disease is a growing threat for immunocompromised patients. The optimum time to use mould-active antifungal agents is much debated. Current approaches to antifungal prophylaxis, early treatment (empirical and pre-emptive therapy) and treatment of documented mould infections in onco-haematology patients are discussed.
eng
60_published
true
University of Lausanne
mailto:serval_help@unil.ch
http://www.unil.ch/serval
http://serval.unil.ch/disclaimer
https://serval.unil.ch/notice/serval:BIB_92AEB095500C